Nirsevimab and Acute Bronchiolitis Admissions in Infants Under One Year of Age

During the first nirsevimab campaign, most bronchiolitis admissions involved healthy children over 6 months of age who were not included in the target population, eligible infants who were not immunized, and immunized infants with non-RSV bronchiolitis. Further studies are needed to analyze the characteristics of immunized patients who are admitted with RSV bronchiolitis.

Authors

Institutions

Publication Details

Journal
Pediatric Pulmonology
Published
2025-08-01
DOI
https://doi.org/10.1002/ppul.71249
Citations
3
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
4.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nirsevimab and Acute Bronchiolitis Admissions in Infants Under One Year of Age

David Andina Martínez, Amaia Cámara Otegui, Clara Ferrero García‐Loygorri, José Lorenzo Guerra Díez et al.
3 citations
Pediatric Pulmonology
Respiratory viral infections research
4.06
article

Nirsevimab and Acute Bronchiolitis Admissions in Infants Under One Year of Age

David Andina Martínez, Amaia Cámara Otegui, Clara Ferrero García‐Loygorri, José Lorenzo Guerra Díez, Nerea González Arza, Adrián Ranera Málaga, Manuel Gijón Mediavilla, Svetlana Pavlovic Nesic, José Antonio Alonso‐Cadenas, Verónica Gimeno‐Hernández Garza, Gemma Claret Teruel, Silvia Escalada Pellitero, Beatriz Jiménez de la Jara, Victoria Sánchez Tatay, Laura Baños López, Clara Barrueco Ramos, Esther Fernández Mozo
article en
3 citations

Abstract

During the first nirsevimab campaign, most bronchiolitis admissions involved healthy children over 6 months of age who were not included in the target population, eligible infants who were not immunized, and immunized infants with non-RSV bronchiolitis. Further studies are needed to analyze the characteristics of immunized patients who are admitted with RSV bronchiolitis.

Pediatric PulmonologyVol. 60(8)
Hospital Sant Joan de Déu Barcelona (ES), Hospital Universitario Insular de Gran Canaria (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Hospital General Universitario Gregorio Marañón (ES), Complejo Hospitalario de Navarra (ES), Marqués de Valdecilla University Hospital (ES), Biogipuzkoa Health Research Institute (ES), Hospital Universitario 12 De Octubre (ES), Hospital Infantil Universitario Niño Jesús (ES), Hospital Universitario Miguel Servet (ES), Corporació Sanitària Parc Taulí (ES), Sant Joan de Déu Research Foundation (ES), Hospital Universitario de La Princesa (ES), Institute of Research and Innovation Parc Tauli (ES), Complexo Hospitalario Universitario A Coruña (ES), Hospital Universitario Virgen de la Arrixaca (ES), Hospital Universitario Virgen del Rocío (ES), Institut de Recerca Sant Joan de Déu, Universitat de Barcelona (ES), Universidad de Navarra (ES)
Openalex Percentile: Top 6%
Respiratory viral infections research
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.